Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

MYC translocation + BCL2 translocation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

MYC translocation + BCL2 translocation	Diffuse Large B Cell Lymphoma	MYC translocation + BCL2 translocation	Diffuse Large B Cell Lymphoma	Sensitive: C3 – Early Trials Sensitive : C3	Sensitive: C3 – Early Trials Sensitive : C3
MYC translocation + BCL2 translocation	Non-Hodgkin’s Lymphoma	MYC translocation + BCL2 translocation	Non-Hodgkin’s Lymphoma	T-lymphocyte cell therapy Sensitive: C3 – Early Trials T-lymphocyte cell therapy Sensitive : C3	T-lymphocyte cell therapy Sensitive: C3 – Early Trials T-lymphocyte cell therapy Sensitive : C3
MYC translocation + BCL2 translocation	Lymphoma	MYC translocation + BCL2 translocation	Lymphoma	lenalidomide Sensitive: C3 – Early Trials lenalidomide Sensitive : C3	lenalidomide Sensitive: C3 – Early Trials lenalidomide Sensitive : C3